HUP0202738A3 - Equine herpes virus temperature sensitive mutant and live vaccine thereof - Google Patents

Equine herpes virus temperature sensitive mutant and live vaccine thereof

Info

Publication number
HUP0202738A3
HUP0202738A3 HU0202738A HUP0202738A HUP0202738A3 HU P0202738 A3 HUP0202738 A3 HU P0202738A3 HU 0202738 A HU0202738 A HU 0202738A HU P0202738 A HUP0202738 A HU P0202738A HU P0202738 A3 HUP0202738 A3 HU P0202738A3
Authority
HU
Hungary
Prior art keywords
temperature sensitive
herpes virus
live vaccine
sensitive mutant
equine herpes
Prior art date
Application number
HU0202738A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HUP0202738A2 publication Critical patent/HUP0202738A2/hu
Publication of HUP0202738A3 publication Critical patent/HUP0202738A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU0202738A 1999-09-10 2000-09-11 Equine herpes virus temperature sensitive mutant and live vaccine thereof HUP0202738A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202933 1999-09-10
PCT/EP2000/008944 WO2001017553A1 (en) 1999-09-10 2000-09-11 Equine herpes virus temperature sensitive mutant and live vaccine thereof

Publications (2)

Publication Number Publication Date
HUP0202738A2 HUP0202738A2 (hu) 2002-12-28
HUP0202738A3 true HUP0202738A3 (en) 2003-12-29

Family

ID=8240619

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202738A HUP0202738A3 (en) 1999-09-10 2000-09-11 Equine herpes virus temperature sensitive mutant and live vaccine thereof

Country Status (8)

Country Link
EP (1) EP1216054A1 (hu)
JP (1) JP2004532601A (hu)
AU (1) AU778157B2 (hu)
CA (1) CA2383980A1 (hu)
HU (1) HUP0202738A3 (hu)
MX (1) MXPA02002566A (hu)
RU (1) RU2252253C2 (hu)
WO (1) WO2001017553A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (en) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh gM-negative EHV-mutants
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
US5972666A (en) * 1996-07-26 1999-10-26 G. D. Searle & Co. Assembly-deficient herpesvirus vaccine
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same

Also Published As

Publication number Publication date
EP1216054A1 (en) 2002-06-26
MXPA02002566A (es) 2002-10-23
CA2383980A1 (en) 2001-03-15
JP2004532601A (ja) 2004-10-28
HUP0202738A2 (hu) 2002-12-28
AU1271101A (en) 2001-04-10
RU2252253C2 (ru) 2005-05-20
RU2002109231A (ru) 2004-02-27
WO2001017553A1 (en) 2001-03-15
AU778157B2 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
GB2337755B (en) Virus vaccine
PT1150712E (pt) Formulações para a vacina do vírus do papiloma humano
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
EP1112091A4 (en) FAST DEEP TEMPERATURE PRESSURE STERILIZATION AND VACCINE PRODUCTION
HUP0004360A2 (en) Papilloma virus capsomere vaccine formulations and methods of use
FR07C0064I1 (fr) Produits d'addition et vaccins
HUP0103908A3 (en) Novel infulenza virus vaccine composition
ZA975619B (en) Recombinant live vaccine based on canine herpesvirus in particular against carre's disease rabies or the para-influenza virus type 2
HK1048436A1 (en) Vaccine against hbv and hpv
IL148247A (en) Vaccine and its uses
PL352212A1 (en) Dna vaccines for domestic and sports animals
ZA200108263B (en) Novel recombinant and mutant herpesviruses.
EP1204424A4 (en) VACCINES AND RECOMBINANT RS VIRUS EXPRESSION SYSTEMS
IL131212A0 (en) Recombinant virus and live-virus vaccines
HUP9701586A3 (en) Improved inactivated vaccines
AU4529401A (en) Aids ancestral viruses and vaccines
DK1248650T3 (da) Forbedrede DNA-vacciner til bovint herpesvirus 1
HUP0202770A3 (en) Human papilloma virus vaccine
HUP0202738A3 (en) Equine herpes virus temperature sensitive mutant and live vaccine thereof
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
IL143149A0 (en) Stable, attenuated rabies virus mutants and live vaccines thereof
EP1023083A4 (en) VETERINARY VACCINES
DK1180041T3 (da) Vaccine med ISA-virus
GB9702990D0 (en) Virus vaccine
HUP0203831A3 (en) Vaccination against canine herpesvirus infection and vaccines

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees